Bulgaria vs Tonga: Cause of death, by non-communicable diseases, ages 0-4, male
Bulgaria
38.2%
in 2021
Tonga
38.6%
in 2021
Bulgaria rank
57th
Tonga rank
54th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Bulgaria
- Tonga
How they compare
Tonga currently reports 38.6% against 38.2% in Bulgaria, a difference of 0.4%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Bulgaria ahead.
Bulgaria ranks 57th and Tonga ranks 54th of 185 countries.
Across the 3 decades both report, Bulgaria averaged higher in 1 and Tonga in 2.
Head to head by decade
| Decade | Bulgaria | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.9% | 34.0% | 0.9% | Bulgaria |
| 2010s | 36.2% | 37.8% | 1.5% | Tonga |
| 2020s | 35.3% | 38.5% | 3.2% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Bulgaria or Tonga?
- Tonga, at 38.6% against 38.2% in Bulgaria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Bulgaria and Tonga?
- 0.4%, with Tonga ahead.
- How many years of comparable data are there for Bulgaria and Tonga?
- 6 years are reported by both, from 2000 to 2021.
- How do Bulgaria and Tonga rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Bulgaria ranks 57th and Tonga ranks 54th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.